LOADING
Comparing Costco Wholesale (COST) and Pfizer Inc (PFE) across the Consumer Staples and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | COST | PFE |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $420.9B | $149.3B |
| P/E Ratio | 47.4 | 34.0 |
| Forward P/E | 42.0 | 8.7 |
| PEG Ratio | 4.62 | 2.99 |
| EPS | $20.03 | $0.77 |
| Revenue Growth (YoY) | 21.5% | 2.6% |
| Profit Margin | 3.0% | 6.8% |
| Return on Equity | 29.1% | 5.0% |
| Dividend Yield | 0.57% | 6.66% |
| Beta | 0.86 | 0.28 |
| 52-Week High | $1,094.76 | $27.80 |
| 52-Week Low | $840.35 | $22.03 |
| Volume | -- | -- |
Costco Wholesale is the larger company by market capitalization. Pfizer Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Pfizer Inc offers a higher dividend yield for income investors. Pfizer Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.